QUOTED. 7 December. Tomas Landh.
Executive Summary
An expert panel recently discussed the complex issues surrounding metabesity. See what panelist Tomas Landh, vice president of innovation sourcing, Novo Nordisk said about it here.
“[At] Novo Nordisk we came to the realization very early on that 99% if not even 99.9% of innovation in this area occurs outside Novo Nordisk premises.” – Tomas Landh, vice president innovation sourcing, Novo Nordisk
Click here for a free trial of Medtech Insight